These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1690535)

  • 1. Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis.
    Lozzi L; Rustici M; Corti M; Cusi MG; Valensin PE; Bracci L; Santucci A; Soldani P; Spreafico A; Neri P
    Arch Virol; 1990; 110(3-4):271-6. PubMed ID: 1690535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.
    Wolinsky JS; Sukholutsky E; Moore WT; Lovett A; McCarthy M; Adame B
    J Virol; 1993 Feb; 67(2):961-8. PubMed ID: 7678312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and antigenic activity of rubella E1 glycoprotein synthetic peptides.
    Neri P; Corti M; Lozzi L; Valensin PE
    Biopolymers; 1991 May; 31(6):631-5. PubMed ID: 1932562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58.
    Bonci A; Bracci L; Caudai C; Lozzi L; Moschettini D; Niccolai N; Scarselli M; Valensin PE; Neri P
    Eur J Biochem; 1993 Jul; 215(2):383-7. PubMed ID: 7688304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of the rubella E1 epitopes.
    Terry GM; Ho-Terry L; Londesborough P; Rees KR
    Arch Virol; 1988; 98(3-4):189-97. PubMed ID: 2450528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies directed to E1 glycoprotein of rubella virus.
    Umino Y; Sato TA; Katow S; Matsuno T; Sugiura A
    Arch Virol; 1985; 83(1-2):33-42. PubMed ID: 2578781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus.
    Chaye H; Chong P; Tripet B; Brush B; Gillam S
    Virology; 1992 Aug; 189(2):483-92. PubMed ID: 1379391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of synthetic peptides with sequences of rubella virus E1 polypeptide by antibodies and T lymphocytes.
    Ilonen J; Seppänen H; Närvänen A; Korkolainen M; Salmi AA
    Viral Immunol; 1992; 5(3):221-8. PubMed ID: 1384533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of N-linked glycosylation on the antigenicity and immunogenicity of rubella virus E1 glycoprotein.
    Qiu Z; Tufaro F; Gillam S
    Virology; 1992 Oct; 190(2):876-81. PubMed ID: 1381541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological characterisation of the rubella E 1 glycoprotein. Brief report.
    Ho-Terry L; Terry GM; Cohen A; Londesborough P
    Arch Virol; 1986; 90(1-2):145-52. PubMed ID: 2425779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bio-engineered rubella E1 antigen.
    Terry GM; Ho-Terry L; Londesborough P; Rees KR
    Arch Virol; 1989; 104(1-2):63-75. PubMed ID: 2647062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E1 glycoprotein of rubella virus carries an epitope that binds a neutralizing antibody.
    Trudel M; Nadon F; Séguin C; Amarouch A; Payment P; Gillam S
    J Virol Methods; 1985 Dec; 12(3-4):243-50. PubMed ID: 2422194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate.
    Perrenoud G; Messerli F; Thierry AC; Beltraminelli N; Cousin P; Fasel N; Vallet V; Demotz S; Duchosal MA; Moulon C
    Vaccine; 2004 Dec; 23(4):480-8. PubMed ID: 15530696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein.
    van der Heijden RW; Langedijk JP; Groen J; UytdeHaag FG; Meloen RH; Osterhaus AD
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1539-45. PubMed ID: 7688410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
    Roehrig JT; Bolin RA; Kelly RG
    Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus.
    Arbiza J; Taylor G; López JA; Furze J; Wyld S; Whyte P; Stott EJ; Wertz G; Sullender W; Trudel M
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2225-34. PubMed ID: 1383404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides.
    McCarthy M; Lovett A; Kerman RH; Overstreet A; Wolinsky JS
    J Virol; 1993 Feb; 67(2):673-81. PubMed ID: 7678302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of a recombinant rubella E1 antigen expressed in E. coli.
    Londesborough P; Terry G; Ho-Terry L
    Arch Virol; 1992; 122(3-4):391-7. PubMed ID: 1731700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis, immunogenicity and antigenic characteristics of the glycoprotein E fragments from the tick-borne encephalitis virus].
    Volkova TD; Vol'pina OM; Zhmak MN; Ivanov VT; Vorovich MF; Timofeev AV
    Bioorg Khim; 2001; 27(3):174-9. PubMed ID: 11443938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome.
    Mauracher CA; Mitchell LA; Tingle AJ
    J Immunol; 1993 Aug; 151(4):2041-9. PubMed ID: 8345195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.